UCLA Tests Smarter Chemo for Ovarian Cancer Patients

Two groundbreaking UCLA trials are testing antibody-drug conjugates that deliver chemotherapy directly to ovarian cancer cells, potentially improving outcomes while reducing harsh side effects.

The treatments could offer more personalized, effective options for women newly diagnosed with the disease.